The US Senate on 21 April approved a $484bn spending package providing tens of billions of dollars to compensate Medicare suppliers that have already supplied diagnoses, testing supplies and personal protection equipment (PPE) to detect the coronavirus, and $25bn more to expand COVID-19 testing.
House members, almost all of whom are self-quarantining or working in their home districts since the end of March, have...







